Prostatype Genomics: Outlook after Q3 - Redeye

Prostatype are making good European launch progress with clinical evaluations, ongoing evaluations and a pipeline of new evaluations. This is a vital step towards repeat sales and clinical use of Prostatype. This progress is balanced by the fact that ongoing actual sales are still very modest.

Länk till analysen i sin helhet: https://www.redeye.se/research/862835/prostatype-genomics-outlook-after-q3?utm_source=finwire&utm_medium=RSS